3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman
We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to discuss diffuse large B-cell lymphoma (DLBCL). We talk about bad cancer drugs and bad Twitter users.